[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gonorrhea Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: G313EE6A2AABEN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Gonorrhea Drug pipeline report- 2020 is an annual R&D review of Gonorrhea pipeline candidates. The report presents the current status of all major Gonorrhea therapeutic compounds. Detailed insights into Gonorrhea pipeline development, current status, companies, drug profiles and Gonorrhea preclinical and clinical trials are included.

2020 Gonorrhea Pipeline Market Insights
Gonorrhea disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Gonorrhea therapies, pipeline by phase and others are included.

Gonorrhea pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Gonorrhea Therapeutic Drug candidates
Both active and inactive Gonorrhea pipeline drug candidates are included in the report

Gonorrhea Clinical Trials and preclinical Studies
Gonorrhea In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Gonorrhea pipeline market developments
Gonorrhea Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Gonorrhea pipeline companies in active development
The report analyzes Gonorrhea pipeline of the below companies-

Biolytics Pharma, Boulos and Cooper Pharmaceuticals Pty Ltd, Debiopharm International SA, Entasis Therapeutics Inc, Evofem Biosciences Inc, GlaxoSmithKline Plc, Melinta Therapeutics Inc , Merck & Co Inc, Microbiotix Inc, Pharmiva AB , Redx Pharma Plc , Summit Therapeutics, TherapyX Inc, Yaso Therapeutics Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
14 Companies investing in Gonorrhea pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Gonorrhea pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. GONORRHEA PIPELINE MARKET INSIGHTS, 2020

1.1 Gonorrhea Disease Overview
1.2 Gonorrhea Drug Pipeline Snapshot, 2020
  1.2.1 Gonorrhea Pipeline Drugs by Phase
  1.2.2 Gonorrhea Pipeline Drugs by Company
  1.2.3 Gonorrhea Pipeline Drugs by Mechanism of Action
  1.2.4 Gonorrhea Pipeline Drugs by Route of Administration

2. GONORRHEA COMPANY WISE PIPELINE DETAILS

Biolytics Pharma Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Boulos and Cooper Pharmaceuticals Pty Ltd Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Debiopharm International SA Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Entasis Therapeutics Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Evofem Biosciences Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Melinta Therapeutics Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Merck & Co Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Microbiotix Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pharmiva AB Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Redx Pharma Plc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Summit Therapeutics Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
TherapyX Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details
Yaso Therapeutics Inc Gonorrhea Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. GONORRHEA DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. GONORRHEA PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications